Jean-antoine A. Ribeil
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.
Journal: HemaSphere
Published: November 26, 2025
Selective AMPKβ1 activation induces fetal hemoglobin in human erythroid cells and sickle cell mice via the noncanonical NRF2 pathway.
Journal: Science advances
Published: November 19, 2025
Initial outcomes in a sickle cell disease transition clinic.
Journal: Health care transitions
Published: December 23, 2023
Gene-addition/editing therapy in sickle cell disease.
Journal: Presse medicale (Paris, France : 1983)
Published: November 24, 2023
An integrated therapeutic approach to sickle cell disease management beyond infancy.
Journal: American journal of hematology
Published: November 14, 2022
Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.
Journal: American journal of hematology
Published: July 12, 2022
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
Journal: The New England journal of medicine
Published: December 13, 2021
Primary myelofibrosis in untreated sickle cell disease: Are adult patients at higher risk for developing hematological myeloid neoplasms?
Journal: American journal of hematology
Published: September 30, 2021
Pregnancy outcome in women with transfused beta-thalassemia in France.
Journal: Annals of hematology
Published: April 23, 2021
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial.
Journal: Nature medicine
Published: December 08, 2020
Last Updated: 09/26/2026